Abel De La Rosa
CIK: 0001825983
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dogwood Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 16, 2026DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
16.8K shares- - Jun 27, 2025DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
2.4K shares- - Jun 18, 2025DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
210 shares- - Jun 18, 2025DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
210 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 | DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 16,800 | - | - | Direct |
| Jun 27, 2025 | DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 2,362 | - | - | Direct |
| Jun 18, 2025 | DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 210 | - | - | Direct |
| Jun 18, 2025 | DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 210 | - | - | Direct |
1-4 of 4 transactions
About De La Rosa Abel
De La Rosa Abel (SEC CIK 0001825983) files insider reports with the SEC as Director of Dogwood Therapeutics, Inc. (DWTX).
Signal8 holds 3 ownership filings by De La Rosa Abel, all Form 4s, filed between Jun 23, 2025 and Jun 17, 2026. Those filings report 4 transactions, from Jun 18, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on De La Rosa Abel's filings is in ALPHARETTA, GA.
Recent filings by De La Rosa Abel
Other insiders filing for Dogwood Therapeutics, Inc. (DWTX)
- Sealbond Ltd, Director
- Thomas John C, Director
- Whitley Richard James, Director
- Keefer David R, Director
- Grosswald Ralph, SVP OF OPERATIONS
- Walsh Angela, Chief Financial Officer